Vaniqa

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2005
01220012005

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
  • B Thiebot
  • Annales de dermatologie et de venereologie
  • 2005
 
Is this relevant?
Review
2005
Review
2005
  • Serge Dahan
  • Annales de dermatologie et de venereologie
  • 2005
 
Is this relevant?
2001
2001
Eflornithine HCl 13.9% cream is the first topical prescription treatment to be approved by the US FDA for the reduction of… (More)
Is this relevant?
2001
2001
Eflornithine HCl 13.9% cream (Vaniqa) is a novel treatment for the management of unwanted facial hair in women. This paper… (More)
Is this relevant?